QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 发表日期：2022     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 The Prognostic Utility of F-18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients 期刊论文 FRONTIERS IN ONCOLOGY, 2022, 卷号: 12 作者:  Li, Cong;  Yu, Haifeng;  Chen, Xi;  Han, Shuiyun;  Peng, Shuailing 收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23 diffuse large B cell lymphoma (DLBCL)  interim 18 F-FDG PET  prognosis  RCHOP  treatment response   Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma 期刊论文 BLOOD ADVANCES, 2022, 卷号: 6 作者:  Yang, Haiyan;  Xiang, Bing;  Song, Yuqin;  Zhang, Huilai;  Zhao, Weili 收藏  |  浏览/下载：16/0  |  提交时间：2022/12/23 Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文 CLINICAL CANCER RESEARCH, 2022, 卷号: 28 作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng 收藏  |  浏览/下载：29/0  |  提交时间：2022/05/05 Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2 期刊论文 LEUKEMIA, 2022 作者:  Yang, Jing;  Weisberg, Ellen L.;  Qi, Shuang;  Ni, Wei;  Mei, Husheng 收藏  |  浏览/下载：76/0  |  提交时间：2022/02/14 Repressing MYC by targeting BET synergizes with selective inhibition of PI3K alpha against B cell lymphoma 期刊论文 CANCER LETTERS, 2022, 卷号: 524, 页码: 206-218 作者:  Chen, Zi-qi;  Cao, Zhe-rui;  Wang, Yi;  Zhang, Xi;  Xu, Lan 收藏  |  浏览/下载：53/0  |  提交时间：2021/12/16 CYH33  MYC  P300  BET  B cell lymphoma  PI3K   Physical characteristics of plasma exosomes from patients with lymphoma based on AFM 期刊论文 生物化学与生物物理进展, 2022, 页码: 1-14 作者:  Li XX(李鑫鑫);  Liu ZH(刘志华);  Wang XL(王鑫磊);  Wang WX(王文学);  Xing XJ(邢晓静) 收藏  |  浏览/下载：25/0  |  提交时间：2022/05/15 lymphoma  peripheral blood  exosome  atomic force microscopy